Journal
Journal for Immunotherapy of Cancer
Publication Date
5-1-2022
Volume
10
Issue
5
First Page
e003956
Document Type
Open Access Publication
DOI
10.1136/jitc-2021-003956
Rights and Permissions
Govindan R, Aggarwal C, Antonia SJ, Davies M, Dubinett SM, Ferris A, Forde PM, Garon EB, Goldberg SB, Hassan R, Hellmann MD, Hirsch FR, Johnson ML, Malik S, Morgensztern D, Neal JW, Patel JD, Rimm DL, Sagorsky S, Schwartz LH, Sepesi B, Herbst RS. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma. J Immunother Cancer. 2022 May;10(5):e003956. doi.org/10.1136/jitc-2021-003956 https://jitc.bmj.com/content/10/5/e003956 http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.
Recommended Citation
Govindan, Ramaswamy; Aggarwal, Charu; Antonia, Scott J; Davies, Marianne; Dubinett, Steven M; Ferris, Andrea; Forde, Patrick M; Garon, Edward B; Goldberg, Sarah B; Hassan, Raffit; Hellmann, Matthew D; Hirsch, Fred R; Johnson, Melissa L; Malik, Shakun; Morgensztern, Daniel; Neal, Joel W; Patel, Jyoti D; Rimm, David L; Sagorsky, Sarah; Schwartz, Lawrence H; Sepesi, Boris; and Herbst, Roy S, "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma." Journal for Immunotherapy of Cancer. 10, 5. e003956 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11944
